These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Skin biopsies for the measurement of clinical pharmacodynamic biomarkers. Phillips RL; Sachs AB Curr Opin Biotechnol; 2005 Dec; 16(6):687-90. PubMed ID: 16257524 [TBL] [Abstract][Full Text] [Related]
25. Metabolic pathway analysis in trypanosomes and malaria parasites. Fairlamb AH Philos Trans R Soc Lond B Biol Sci; 2002 Jan; 357(1417):101-7. PubMed ID: 11839187 [TBL] [Abstract][Full Text] [Related]
26. Detecting drug targets with minimum side effects in metabolic networks. Li Z; Wang RS; Zhang XS; Chen L IET Syst Biol; 2009 Nov; 3(6):523-33. PubMed ID: 19947778 [TBL] [Abstract][Full Text] [Related]
27. Finding the target after screening the phenotype. Hart CP Drug Discov Today; 2005 Apr; 10(7):513-9. PubMed ID: 15809197 [TBL] [Abstract][Full Text] [Related]
28. Transcriptome PETs: a genome's best friends. Peters BA; Velculescu VE Nat Methods; 2005 Feb; 2(2):93-4. PubMed ID: 15782204 [No Abstract] [Full Text] [Related]
29. Exploiting naturally occurring DNA variation and molecular profiling data to dissect disease and drug response traits. Schadt EE Curr Opin Biotechnol; 2005 Dec; 16(6):647-54. PubMed ID: 16249078 [TBL] [Abstract][Full Text] [Related]
30. Discovering tightly regulated and differentially expressed gene sets in whole genome expression data. Ye C; Eskin E Bioinformatics; 2007 Jan; 23(2):e84-90. PubMed ID: 17237110 [TBL] [Abstract][Full Text] [Related]
31. Integrating cell-level kinetic modeling into the design of engineered protein therapeutics. Rao BM; Lauffenburger DA; Wittrup KD Nat Biotechnol; 2005 Feb; 23(2):191-4. PubMed ID: 15696150 [TBL] [Abstract][Full Text] [Related]
32. Prospecting for biocatalysts and drugs in the genomes of non-cultured microorganisms. Streit WR; Daniel R; Jaeger KE Curr Opin Biotechnol; 2004 Aug; 15(4):285-90. PubMed ID: 15296926 [TBL] [Abstract][Full Text] [Related]
34. Different delivery methods-different expression profiles. Fedorov Y; King A; Anderson E; Karpilow J; Ilsley D; Marshall W; Khvorova A Nat Methods; 2005 Apr; 2(4):241. PubMed ID: 15782213 [No Abstract] [Full Text] [Related]
35. Discovery of uncharacterized cellular systems by genome-wide analysis of functional linkages. Date SV; Marcotte EM Nat Biotechnol; 2003 Sep; 21(9):1055-62. PubMed ID: 12923548 [TBL] [Abstract][Full Text] [Related]
36. The heart is already working. Noble D Biochem Soc Trans; 2005 Jun; 33(Pt 3):539-42. PubMed ID: 15916559 [TBL] [Abstract][Full Text] [Related]
37. An iterative algorithm for metabolic network-based drug target identification. Sridhar P; Kahveci T; Ranka S Pac Symp Biocomput; 2007; ():88-99. PubMed ID: 17992747 [TBL] [Abstract][Full Text] [Related]
38. Reconstructing pathways in large genetic networks from genetic perturbations. Wagner A J Comput Biol; 2004; 11(1):53-60. PubMed ID: 15072688 [TBL] [Abstract][Full Text] [Related]
39. Evaluation and integration of 49 genome-wide experiments and the prediction of previously unknown obesity-related genes. English SB; Butte AJ Bioinformatics; 2007 Nov; 23(21):2910-7. PubMed ID: 17921495 [TBL] [Abstract][Full Text] [Related]
40. Drug target prioritization by perturbed gene expression and network information. Isik Z; Baldow C; Cannistraci CV; Schroeder M Sci Rep; 2015 Nov; 5():17417. PubMed ID: 26615774 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]